Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-13-006146
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-01 16:53:33
Reporting Period:
2013-01-30
Filing Date:
2013-02-01
Accepted Time:
2013-02-01 16:53:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1407038 Bg Medicine Inc. BGMD In Vitro & In Vivo Diagnostic Substances (2835) 043506204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1097546 Newcogen Equity Investors Llc C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1097548 Newcogen Group Llc C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1131095 Agtc Advisors Fund Lp C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1222012 Noubar Afeyan C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
Yes No Yes No
1255927 Jr M Edwin Kania C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1399779 Applied Genomic Technology Capital Fund Lp C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1400240 Flagship Ventures Management, Inc. C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1400241 Newcogen Group, Inc. C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1419730 Agtc Partners, L.p. C/o Flagship Ventures
One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-30 250,000 $2.00 2,434,800 No 4 P Indirect By NewcoGen Group LLC
Common Stock Acquisiton 2013-01-30 125,000 $2.00 651,560 No 4 P Indirect By NewcoGen Equity Investors LLC
Common Stock Acquisiton 2013-01-30 75,000 $2.00 215,013 No 4 P Indirect By AGTC Advisors Fund, L.P.
Common Stock Acquisiton 2013-01-30 500,000 $2.00 2,851,447 No 4 P Indirect By Applied Genomic Technology Capital Fund, L.P.
Common Stock Acquisiton 2013-01-30 1,050,000 $2.00 1,764,286 No 4 P Indirect By Flagship Ventures Fund 2007, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By NewcoGen Group LLC
No 4 P Indirect By NewcoGen Equity Investors LLC
No 4 P Indirect By AGTC Advisors Fund, L.P.
No 4 P Indirect By Applied Genomic Technology Capital Fund, L.P.
No 4 P Indirect By Flagship Ventures Fund 2007, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 92,294 Indirect By NewcoGen-Long Reign Holding LLC
Common Stock 92,126 Indirect By ST NewcoGen LLC
Common Stock 4,232 Indirect By OneLiberty Advisors Fund 2000 L.P.
Common Stock 80,424 Indirect By OneLiberty Ventures 2000 L.P.
Footnotes
  1. NewcoGen Group, Inc. ("NG") is the manager of each of NewcoGen Group LLC ("NGG"), NewcoGen Equity Investors LLC ("NEI"), NewcoGen-Long Reign Holding LLC ("NGLRH") and ST NewcoGen LLC ("STN", and together with NGG, NEI and NGLRH, the "NewcoGen Funds"). NG is also the general partner of AGTC Partners, L.P., which is the general partner of AGTC Advisors Fund, L.P. ("AGTCA") and Applied Genomic Technology Capital Fund, L.P. ("AGTCF", and together with AGTCA, the "AGTC Funds"). NG is a wholly-owned subsidiary of Flagship Ventures Management, Inc. ("Flagship"). Noubar Afeyan and Edwin M. Kania, Jr. are directors of Flagship and may be deemed to beneficially own the securities held by the NewcoGen Funds and the AGTC Funds. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  2. Noubar Afeyan and Edwin M. Kania, Jr. are managers of Flagship Ventures 2007 General Partner, LLC, which is the general partner of Flagship Ventures Fund 2007, L.P., and may be deemed to beneficially own the securities held by Flagship Ventures Fund 2007, L.P. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  3. Noubar Afeyan and Edwin M. Kania, Jr. are managing members of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Advisors Fund 2000 L.P. ("OLA") and OneLiberty Ventures 2000 L.P. ("OLV"), and may be deemed to beneficially own the securities held by OLA and OLV. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.